Nano Packaged Tamoxifen and Curcumin; Effective Formulation against Sensitive and Resistant MCF-7 Cells

Tamoxifen is routinely used for treatment of Estrogen-positive breast carcinoma. Approximately, 50% of patients with metastatic cancer will develop resistance to Tamoxifen. In this research, Tamoxifen was combined with the anti-cancer compound Curcumin. Diblocknanopolymer was used to package the new...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Iran J Pharm Res
Huvudupphovsmän: Hajigholami, Samira, Veisi Malekshahi, Ziba, Bodaghabadi, Narges, Najafi, Farhod, Shirzad, Hadi, Sadeghizadeh, Majid
Materialtyp: Artigo
Språk:Inglês
Publicerad: Shaheed Beheshti University of Medical Sciences 2018
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5937073/
https://ncbi.nlm.nih.gov/pubmed/29755534
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk